Search company, investor...
R4 Vascular company logo

R4 Vascular

r4vascular.com

About R4 Vascular

Vascular is driving innovation in vascular access medical technology. The company's passion is uncomplicating venous access, chemotherapy, and drug delivery. The company's product designs offer rapid exchange, Biomimetic coating, power injection ability, and associated improvements that help the company's catheters remain patent and effective. Learn more about how the company's products can improve patient care through reduced complications, while delivering lower overall costs for access and drug delivery.

Headquarters Location

4 Willow Terrace

Hoboken, New Jersey, 07030,

United States

Missing: R4 Vascular's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: R4 Vascular's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

R4 Vascular Patents

R4 Vascular has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/9/2008

12/20/2011

Fluid dynamics, Vascular surgery, Catheters, Edible fungi, Nephrology

Grant

Application Date

6/9/2008

Grant Date

12/20/2011

Title

Related Topics

Fluid dynamics, Vascular surgery, Catheters, Edible fungi, Nephrology

Status

Grant

R4 Vascular Frequently Asked Questions (FAQ)

  • Where is R4 Vascular's headquarters?

    R4 Vascular's headquarters is located at 4 Willow Terrace, Hoboken.

  • Who are R4 Vascular's competitors?

    Competitors of R4 Vascular include PharmaJet, Sol-Gel, Savara, EZRA Innovations, MonoSol Rx and 13 more.

Compare R4 Vascular to Competitors

E
Erydel

EryDel develops a red-blood-cell-based drug delivery device for the treatment of rare neurodegenerative diseases. Its proprietary technology relies upon the encapsulation of drugs into red cells taken from the patient's own blood, which are then re-infused into the patient.

C
Corium International

Corium International applies advanced transdermal delivery systems and related technologies to address unmet medical needs. The company has developed two highly differentiated transdermal technologies: MicroCor, a biodegradable microstructure patch technology for active delivery of proteins, peptides and vaccines large molecules that require active transport through the skin; Corplex, an adhesive system and patch technology for delivery of small molecules that may otherwise be difficult to formulate and deliver.

T
Talima Therapeutics

Talima Therapeutics is an emerging drug delivery company dedicated to the development of novel products that increase patient choice and improve quality of life. With a unique approach to therapy, we design customized drug-delivery systems that optimize the local therapeutic performance and reduce the undesired systemic side effects enabling us to address unmet needs or underserved markets. We foster a collaborative environment and strive for excellence internally and with our partners. Our lead product is currently in Phase I/II clinical testing for the treatment of onychomycosis, a fungal disease of the nails and we are in the process of planning its pivotal trials.

N
NanoPass Technologies

NanoPass Technologies develops and commercializes painless intradermal (skin) delivery solutions for vaccines and large molecules. NanoPass is continuously engaged in joint clinical development with top pharmaceutical companies, to demonstrate the benefits of its technology for various indications.

S
Sindolor

Making the pain of injections go away in children, adults and seniors, is Israel's Sindolor. Based in Ramat Gan, under the TASE-traded mother company D Medical Industries, Sindolor is about to release its EZject drug delivery platform.

M
Medipacs

Medipacs develops a non-mechanical infusion pump using a expandable polymer. TheMedipacs pump is designed to be wearable, programmable and disposable to allow for greater accuracy, patient comfort and convenience at a lower cost. The Medipacs novel polymer technology enables drug infusion pumps that are wearable, programmable and disposable to allow for greater accuracy, patient comfort and convenience at a lower cost.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.